3644 results for «2703»
3644 results
Empowering DES performance in complex patients to maximise efficacy and safety outcomes
20 May 2021 – From EuroPCR 2021
Watch this session presented by Marco Valgimigli, Istvan Ferenc Edes, Antonio Colombo, Rafael Romaguera, Gennaro Sardella and Pieter Stella in order to identify the key elements and actions to be considered to maximise complex PCI outcomes in diabetes mellitus and high bleeding risks patients, to understand how re-PCI impacts...
EuroPCR 2021 Hotlines / Late-Breaking Trials: POEM, CEL-02, and PENDULUM
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in drugs & devices:
- POEM study: 1-month DAPT after PCI with bioresorbable-polymer EES in HBR patients
- CEL-O2 trial: a novel rapid glycoprotein IIb/IIIa inhibitor(RUC-4) for STEMI patients
- PENDULUM registry study: impact of Clinical Outcomes and Platelet Reactivity After Percutaneous Coronary
The new Evolut PRO+ system: optimal procedural outcomes in all patients
20 May 2021 – From EuroPCR 2021
Watch this session presented by Didier Tchetche, Jean Fajadet, Azeem Latib, Anna Sonia Petronio, Daniel Blackman and Tanja Rudolph in order to explore benefits of the new Evolut PRO+ system and its versatility to treat different patient anatomies, to understand how the cusp overlap and commissural alignment techniques can...
Improving personalised vascular care using novel technologies: how can I start?
19 May 2021 – From EuroPCR 2021
Watch this session presented by Salvatore Brugaletta, Nick West, Rasha Al-Lamee, Will Davies, Angela H.E.M. Maas and William Wijns in order to learn more about personalised vascular healthcare, to understand the value of personalised vascular healthcare, and to see practical examples on how this can be implemented in your practice.
Redefining hypertension management with renal denervation
19 May 2021 – From EuroPCR 2021
Watch this session presented by Jeffrey Popma, David Kandzari, Felix Mahfoud and Andrew Sharp in order to understand the latest data on the safety and efficacy of radiofrequency renal denervation including future studies, to learn about the long-term durability of renal denervation in a real-world patient population, and...
Why physiology and co-reg is helpful in treating patients with multivessel disease/diffused disease
20 May 2021 – From EuroPCR 2021
Watch this session presented by Sukhjinder Nijjer, Nick Curzen, Rasha Al-Lamee and Sayan Sen in order to learn about the new pressure guide wire OmniWire and workflow enhancement with Azurion and IntraSight, to understand how "interventional physiology" can guide PCI in diffuse, multivessel coronary artery disease, and to learn how...
Latest insights: when to choose orbital atherectomy
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Surendra Avula and Ajay Kirtane in order to understand the challenges of treating severe calcium, to know about the OAS overview with dual-action MOA technology and the clinical evidence supporting its use, and to be introduced to treatment technique.
Sustained Limus release, redefining indications for drug-eluting balloons
20 May 2021 – From EuroPCR 2021
Watch this session presented by Bernardo Cortese, Kambis Mashayekhi, Jonas Häner and Tuomas Rissanen in order to understand how sustained Limus release technology can broaden DEB indications, to learn how SELUTION SLR sustained Limus DEB performs in daily clinical practice, and to know more about the importance of sustained Limus release technology...
TAVI in a patient with coronary artery disease - Session with LIVE demonstration
18 May 2021 – From EuroPCR 2021
Watch this session if you want to discuss the available data for treating coronary artery disease in patients undergoing TAVI and to understand the role of FFR/IFR in coronary artery disease assessment prior to TAVI.
This session was originally presented during EuroPCR 2021.
How to prevent and manage coronary perforation?
19 May 2021 – From EuroPCR 2021
Watch this session if you want to learn about the different types of coronary perforation, to discuss how to predict which situations and coronary anatomies are particularly at risk of coronary perforation, and to share practical tips for rapid and effective management of coronary perforation.
This session...
Left Main and bifurcation PCI - Session with LIVE demonstration
19 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to adapt your treatment strategy to the underlying anatomy, to learn the steps of provisional left main PCI and to discuss the pitfalls of provisional left main PCI.
This session was originally presented during EuroPCR 2021.
EuroPCR 2021 Hotlines / Late-Breaking Trials in renal denervation: EFFECTIVENESS
25 May 2021 – From EuroPCR 2021
Find out more about the EFFECTIVENESS trial regarding renal denervation.
Coronary access after TAVI, a growing need
20 May 2021 – From EuroPCR 2021
Watch this session presented by Nicolas Van Mieghem, Christopher Meduri, Andreas Ruck, Nawzad Saleh, Joanna Wykrzykowska and Mohamed Abdel-Wahab in order to learn about the growing importance of coronary access after TAVI, to understand how TAVI design and implantation technique has an impact on future coronary access, and to discuss the...
Left atrial appendage closure (LAAc) for stroke prevention - Session with LIVE demonstration
20 May 2021 – From EuroPCR 2021
Watch this session if you want to understand how to select the most suitable patients for LAA closure, to develop an approach to appropriate device selection and procedural planning, to share step-by-step implementation of procedural plans and to explore optimal post procedure follow-up and care.
This session...
Percutaneous mitral treatment: replacement
18 May 2021 – From EuroPCR 2021
Watch this session if you want to understand patient selection for percutaneous mitral treatment, to select percutaneous valve repair or replacement, and to learn tips and tricks in percutaneous valve treatment.
This session was originally presented during EuroPCR 2021.
Renal denervation in the real-world: performance in high risk subgroups
05 Oct 2021 – From AICT-AsiaPCR 2021
After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...
Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients
06 Oct 2021 – From AICT-AsiaPCR 2021
In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...
Treating complex coronary lesions: right case right time Prevail™ DCB
01 Oct 2021 – From AICT-AsiaPCR 2021
Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...
Telescope guide extension catheter in complex coronary interventions
01 Oct 2021 – From AICT-AsiaPCR 2021
View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.
MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
01 Oct 2021 – From AICT-AsiaPCR 2021
In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.
